Theratechnologies Inc. (THTX) reported Q3 EPS of ($0.08), $0.04 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $20.8 million versus the consensus estimate of $20.67 million.
GUIDANCE:
Theratechnologies Inc. sees FY2022 revenue of $79-82 million.